Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Plc Regulatory News (HAYD)

Share Price Information for Haydale Plc (HAYD)

Share Price is delayed by 15 minutes
Get Live Data
0.325    -0.0025 (-0.76%)
Bid:
0.32
Ask:
0.33
Spread: 0.01 (3.125%)
Market Cap: £25.27m
HAYD Live PriceLast checked at - London Stock Exchange

Intraday Haydale Plc Share Chart

Directors Dealing

4 Nov 2014 14:10

HAYDALE GRAPHENE INDUSTRIES PLC - Directors Dealing

HAYDALE GRAPHENE INDUSTRIES PLC - Directors Dealing

PR Newswire

London, November 4

Haydale Graphene Industries plc (the "Company") Director's Dealing The Company was informed on 3 November 2014 that on that day Dr ChristopherSpacie, Technical Director of the Company, purchased 8,312 ordinary shares of2p each in the Company ("Ordinary Shares") at a price of 60p per OrdinaryShare. Following this transaction, Dr Christopher Spacie is now interested in35,463 Ordinary Shares, representing 0.32% of the total voting rights of theCompany of 11,247,823 Ordinary Shares. For further information please contact: Haydale Graphene Industries plc 01269 842 946John Knowles, ChairmanRay Gibbs, Chief Executive Officer Cairn Financial Advisers LLP (Nomad) 020 7148 7900Tony RawlinsonPaul Trendell Cantor Fitzgerald Europe (Broker)David Foreman 020 7894 7684Paul Jewell 020 7894 7644 Hermes Financial PRTrevor Phillips 07889 153 628Chris Steele 07979 604 687
Date   Source Headline
2nd Jun 20147:00 amPRNUS research body reports positively on Haydale's GNPs
27th May 20147:00 amPRNInvestor Open Day
23rd May 201411:36 amPRNDirector's Dealing
22nd May 20149:11 amPRNDirector's Dealing
14th May 20147:00 amPRNAppointment of Joint Broker
1st May 20145:33 pmPRNHolding(s) in Company
29th Apr 20147:00 amPRNResponse to press comments
23rd Apr 20142:59 pmPRNHolding(s) in Company
23rd Apr 201411:23 amPRNDirector/PDMR Shareholding
16th Apr 20141:49 pmPRNDirector's Dealing
14th Apr 20147:00 amPRNFirst day of dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.